STAT

Opinion: Uwe Reinhardt’s ‘Priced Out’ offers lessons in health care costs for all

To Uwe Reinhardt, the elephant in the room in health care debates has always been this fundamental question: To what extent we should be our poor and sick brothers' and…

I had the pleasure — and the misfortune — of publishing several articles with Uwe Reinhardt, the legendary Princeton economist who died in 2017 as a very young 80-year-old.

The pleasure was that Uwe was a great co-author with amazing insights. His ability to present complex ideas in an accessible way will be clear if you read his just-published final book, “Priced Out,” which explores the economic and ethical costs of health care in the U.S.

The misfortune

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

Related Books & Audiobooks